in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Hovione to Buy Irish Pharma Ingredients Site from Pfizer
12:58 PM MST | December 19, 2008 | Alex Scott
Hovione (Loures, Portugal) says it has agreed to buy Pfizer’s multipurpose active pharmaceutical ingredient (API) plant at Loughbeg, Ireland. The deal is scheduled to be completed by early April 2009. Financial terms were not disclosed. Loughbeg: Hovione eyes first site in Ireland. The site, to be renamed Hovione Cork, manufactures intermediates for APIs for Pfizer’s cholesterol-lowering drug Lipitor. Hovione, which has plants in Portugal and China, says it will continue to provide manufacturing services for Pfizer under the deal. Hovione Cork will...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee